Sign in

Matt McNeil

@mattmcneil86.bsky.social
70 followers 142 following 4 posts
PostsRepliesMedia
Matt McNeil @mattmcneil86.bsky.social · 14/04/2026
Excited that our group was able to contribute to this awesome work led by Richard Payne and Isabel Barter exploring the how different ClpC1 targeting peptides can have distinct impacts on the proteome of Mycobacterium tuberculosis. www.nature.com/articles/s41...
nature.com
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis - Nature Communications
In this work, the authors reveal that three non-ribosomal peptides targeting a common protein quality system differentially alter the Mycobacterium tuberculosis proteome, providing new insight into th...
000
Matt McNeil @mattmcneil86.bsky.social · 14/04/2026
Really excited that our group was able to contribute to this work showing that the dormancy regulon of M. tuberculosis experienced reductive evolution as it adapted to human populations. Great work led by Sarah Dunstan and Matt Silcocks!! www.nature.com/articles/s41...
nature.com
Dormancy regulon reduction was pivotal to the evolution of Mycobacterium tuberculosis - Nature Communications
Mycobacterium tuberculosis owes its success partly to its ability to enter a ‘dormant’, non-replicative state, reactivating years or even decades after initial infection. In this work, authors find th...
000
Matt McNeil @mattmcneil86.bsky.social · 30/05/2025
Really excited that our group was able to contribute to this awesome work from Bing Zhang and Zihe Rao solving the structure and assembly of the MmpS5L5 efflux pump from Mtb!! www.nature.com/articles/s41...
nature.com
Structure and assembly of the MmpL5/MmpS5 efflux transporter from Mycobacterium tuberculosis - Nature Communications
The MmpL5/MmpS5 efflux system is crucial for drug extrusion and siderophore export in M. tuberculosis. Here, the authors report its high-resolution cryo-EM structures, revealing a unique trimeric asse...
0116
Matt McNeil @mattmcneil86.bsky.social · 24/04/2025
Super excited that this manuscript investigating verapamil potentiation of bedaquiline in M. tuberculosis is now in PNAS!! Great collaborative effort with Lalita Ramakrishnan and her team at the MRC-LMB!! www.pnas.org/doi/10.1073/... @pnas.org @universityofotago.bsky.social
pnas.org
Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity | PNAS
Bedaquiline is the cornerstone of a new regimen for the treatment of drug-resistant tuberculosis. However, its clinical use is threatened by the em...
0117
Reposted by Matt McNeil
Feargal Ryan @feargalr.bsky.social · 03/04/2025
Delighted our study (7+ years in the making) is out today in Nature. In a nutshell, 48 hours of antibiotics in week 1 led to impaired vaccine responses up to 15 months later in infants. We show (in-vivo) a probiotic can fix it #microbiome #science #immunology www.nature.com/articles/s41...
nature.com
Bifidobacteria support optimal infant vaccine responses - Nature
Neonatal antibiotic use is shown to reduce immune response to infant vaccines, accompanied by reduced abundance of Bifidobacteria in the gut microbiota, with experiments in mice indicating that probio...
713758